REGENERATIVE MEDICAL TECHNOLOGY GROUP INC.

Regenerative Medical Technology Group Inc.

MSSV

US59071L1035

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 02:57:17 2024-07-05 pm EDT			5-day change	1st Jan Change
0.0425 ^USD	-3.91%		+21.43%	+482.19%

May. 20	Regenerative Medical Technology Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 15	Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Oriens Travel and Hotel Management Corp. Appoints Melvin Pereira as New Chief Executive Officer, President & Director

September 23, 2014 at 08:16 am EDT

Oriens Travel & Hotel Management Corp. announced that the company has appointed Mr. Melvin Pereira as its new Chief Executive Officer, President & Director.

Latest news about Regenerative Medical Technology Group Inc.

Regenerative Medical Technology Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 20	CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 15	CI
Meso Numismatics, Inc. will Change its Name to Regenerative Medical Technology Group Inc	Mar. 04	CI
Meso Numismatics, Inc. Announces New Clinics	Jan. 31	CI
Meso Numismatics, Inc. Reports Sales Results for the Year 2023	Jan. 31	CI
Meso Numismatics, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Jan. 31	CI
Meso Numismatics, Inc. announced that it expects to receive $10 million in funding from GHS Investments, LLC	Dec. 07	CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-14	CI
Meso Numismatics, Inc. Auditor Raises 'Going Concern' Doubt	23-04-13	CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Meso Numismatics, Inc.'s Global Stem Cells Group Announces Launch of New Stem Cells and Regenerative Medicine Clinic in CDMX	22-10-28	CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Meso Numismatics, Inc. Expands its Stem Cell Therapy and Regenerative Medicine Centers to Indonesia	22-08-01	CI
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-19	CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-05	CI
Meso Numismatics, Inc. Auditor Raises 'Going Concern' Doubt	22-05-04	CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-12-22	CI
Meso Numismatics, Inc. completed the acquisition of Global Stem Cells Group, Inc. from Benito Novas.	21-08-17	CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-13	CI
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-13	CI
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	21-01-07	CI

Chart Regenerative Medical Technology Group Inc.

Duration

Period

Chart Regenerative Medical Technology Group Inc.

More charts

Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
REGENERATIVE MEDICAL TECHNOLOGY GROUP INC.	+482.19%	531K
MODERNA, INC.	+18.97%	45.34B
LONZA GROUP AG	+41.98%	40.42B
IQVIA HOLDINGS INC.	-10.06%	37.92B
ALNYLAM PHARMACEUTICALS, INC.	+31.15%	31.75B
CELLTRION, INC.	-7.79%	27.71B
ICON PUBLIC LIMITED COMPANY	+13.32%	26.52B
UNITED THERAPEUTICS CORPORATION	+43.05%	13.96B
MEDPACE HOLDINGS, INC.	+31.28%	12.44B
BIO-TECHNE CORPORATION	-7.41%	11.26B

Other Biotechnology & Medical Research

Regenerative Medical Technology Group Inc.

Equities

MSSV

US59071L1035

Biotechnology & Medical Research

Oriens Travel and Hotel Management Corp. Appoints Melvin Pereira as New Chief Executive Officer, President & Director

Latest news about Regenerative Medical Technology Group Inc.

Chart Regenerative Medical Technology Group Inc.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research